Business Context and Reporting Period
This Form 8-K filing by Emergent BioSolutions Inc. reports on events occurring on November 7, 2011. The filing details the adoption of a new Senior Management Severance Plan by the Board of Directors, effective immediately, replacing the previous plan adopted in May 2006 for designated executives.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. This report focuses exclusively on executive compensation arrangements and severance terms.
Material Changes
The primary material change is the implementation of the new Severance Plan, which alters the compensation structure for terminated executives. Key participants and their severance entitlements upon termination without cause are as follows:
- Fuad El-Hibri: 150% of base salary and bonus; 18 months of continued benefits.
- Daniel J. Abdun-Nabi: 125% of base salary and bonus; 15 months of continued benefits.
- R. Don Elsey: 100% of base salary and bonus; 12 months of continued benefits.
- Adam Havey: 125% of base salary and bonus; 15 months of continued benefits.
Payments are generally made in equal monthly installments over the benefit period, except for unpaid salary and expenses which are paid in a lump sum within 30 days.
Guidance, Outlook, and Risks
Change of Control Provisions: If a participant is terminated without cause or resigns for good reason within 18 months of a change of control, severance increases significantly, and equity awards vest immediately.
- Fuad El-Hibri: 250% of base salary and bonus; 30 months of benefits.
- Daniel J. Abdun-Nabi: 200% of base salary and bonus; 24 months of benefits.
- R. Don Elsey: 100% of base salary and bonus; 12 months of benefits.
- Adam Havey: 200% of base salary and bonus; 24 months of benefits.
Conditions and Restrictions: Receipt of severance is contingent upon the executive signing a waiver and release of claims and adhering to non-solicitation and non-compete restrictions for the duration of the benefit period. Payments may be delayed by six months for "specified employees" under Section 409A of the Internal Revenue Code.
Investor Verification Checklist
- Verify the specific base salary and target bonus figures for the named executives to calculate potential severance liabilities.
- Review the definition of "Cause" and "Good Reason" within the full Severance Plan text (Exhibit 10.1) to understand termination triggers.
- Assess the impact of the increased change-of-control payouts on potential acquisition costs.
- Confirm the number of employees currently designated under the plan (up to 35 or 7% of total workforce).